ID

43958

Description

A Study of IL-12 in Patients With Acute Myelogenous Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT02483312

Lien

https://clinicaltrials.gov/show/NCT02483312

Mots-clés

  1. 01/04/2016 01/04/2016 -
  2. 20/09/2021 20/09/2021 -
Téléchargé le

20 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Acute Myeloid Leukemia NCT02483312

Eligibility Acute Myeloid Leukemia NCT02483312

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient with aml and >=18 years of age.
Description

AML

Type de données

boolean

Alias
UMLS CUI [1]
C0023467
Patient agrees to participate in the study and signs the informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
viably frozen cells from the time of diagnosis or relapse are available
Description

Peripheral blood mononuclear cell

Type de données

boolean

Alias
UMLS CUI [1]
C1321301
first complete remission and have high risk features of relapse.
Description

In complete remission

Type de données

boolean

Alias
UMLS CUI [1]
C0677874
less than 10% blast cells in the bone marrow following induction or re-induction therapy and not desiring further intensive treatment.
Description

Blast Cell

Type de données

boolean

Alias
UMLS CUI [1]
C0368761
acceptable creatinine, ast, alp, bilirubin
Description

Creatinine

Type de données

boolean

Alias
UMLS CUI [1]
C0010294
agree to use contraception
Description

Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1]
C0700589
not pregnant
Description

Not pregnant

Type de données

boolean

Alias
UMLS CUI [1]
C0232973
able to comply with study procedures
Description

comply with study procedures

Type de données

boolean

Alias
UMLS CUI [1]
C0525058
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
ecog performance status <2
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
known persistent infection
Description

Persistent infection

Type de données

boolean

Alias
UMLS CUI [1]
C1264606
known cns disease
Description

cns disease

Type de données

boolean

Alias
UMLS CUI [1]
C0007682
greater than 10% blasts in the bone marrow or circulating blast cells
Description

Blast Cell

Type de données

boolean

Alias
UMLS CUI [1]
C0368761
life expectancy < 2 months
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
receiving any chemotherapy, corticosteroids, cox2 inhibitors or any non-drug therapies with the intent of altering the immune response or kill leukemic cells within one week prior to infusion of il-12 -infected cells.
Description

Leukemic Cells

Type de données

boolean

Alias
UMLS CUI [1]
C0020964
UMLS CUI [2]
C3890400

Similar models

Eligibility Acute Myeloid Leukemia NCT02483312

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
AML
Item
patient with aml and >=18 years of age.
boolean
C0023467 (UMLS CUI [1])
Informed Consent
Item
Patient agrees to participate in the study and signs the informed consent
boolean
C0021430 (UMLS CUI [1])
Peripheral blood mononuclear cell
Item
viably frozen cells from the time of diagnosis or relapse are available
boolean
C1321301 (UMLS CUI [1])
In complete remission
Item
first complete remission and have high risk features of relapse.
boolean
C0677874 (UMLS CUI [1])
Blast Cell
Item
less than 10% blast cells in the bone marrow following induction or re-induction therapy and not desiring further intensive treatment.
boolean
C0368761 (UMLS CUI [1])
Creatinine
Item
acceptable creatinine, ast, alp, bilirubin
boolean
C0010294 (UMLS CUI [1])
Contraceptive methods
Item
agree to use contraception
boolean
C0700589 (UMLS CUI [1])
Not pregnant
Item
not pregnant
boolean
C0232973 (UMLS CUI [1])
comply with study procedures
Item
able to comply with study procedures
boolean
C0525058 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ECOG performance status
Item
ecog performance status <2
boolean
C1520224 (UMLS CUI [1])
Persistent infection
Item
known persistent infection
boolean
C1264606 (UMLS CUI [1])
cns disease
Item
known cns disease
boolean
C0007682 (UMLS CUI [1])
Blast Cell
Item
greater than 10% blasts in the bone marrow or circulating blast cells
boolean
C0368761 (UMLS CUI [1])
Life Expectancy
Item
life expectancy < 2 months
boolean
C0023671 (UMLS CUI [1])
Leukemic Cells
Item
receiving any chemotherapy, corticosteroids, cox2 inhibitors or any non-drug therapies with the intent of altering the immune response or kill leukemic cells within one week prior to infusion of il-12 -infected cells.
boolean
C0020964 (UMLS CUI [1])
C3890400 (UMLS CUI [2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial